13 Jul R3 Stem Cell Responds to FDA Letter to Reaffirm its Commitment to Public Health and Safety
R3 Stem Cell, LLC (R3), a leader in regenerative therapy practices, issued a formal response to a letter it received from the FDA that raised concerns over alleged unapproved stem cell products to treat a variety of diseases and conditions as well as potential safety...